CRISIL Limited (BOM: 500092)
India
· Delayed Price · Currency is INR
5,399.40
-91.65 (-1.67%)
At close: Jan 21, 2025
CRISIL Revenue
CRISIL had revenue of 8.12B INR in the quarter ending September 30, 2024, with 10.32% growth. This brings the company's revenue in the last twelve months to 32.65B, up 7.25% year-over-year. In the year 2023, CRISIL had annual revenue of 31.40B with 13.39% growth.
Revenue (ttm)
32.65B
Revenue Growth
+7.25%
P/S Ratio
n/a
Revenue / Employee
6.99M
Employees
4,673
Market Cap
395.65B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 31.40B | 3.71B | 13.39% |
Dec 31, 2022 | 27.69B | 4.68B | 20.34% |
Dec 31, 2021 | 23.01B | 3.19B | 16.09% |
Dec 31, 2020 | 19.82B | 2.50B | 14.44% |
Dec 31, 2019 | 17.32B | -167.70M | -0.96% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,398.38B |
Tata Consultancy Services | 2,520.82B |
HDFC Bank | 2,761.06B |
Bharti Airtel | 1,554.78B |
ICICI Bank | 1,638.51B |
Infosys | 1,635.60B |
State Bank of India | 3,360.28B |
ITC Limited | 751.35B |
CRISIL News
- 8 days ago - Top gainers today: Piramal Pharma surges 5.85%, CRISIL rises 3.63%, Aditya Birla Capital gains 2.76%, AstraZeneca Pharma up 2.57% - Business Upturn
- 5 weeks ago - CRISIL invests Rs 33.25 Crore in online PSB Loans - Business Upturn